The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Statement 4.3
“Hospital pharmacists should have access to the patients’ health record. Their clinical interventions should be documented in the patients’ health record and analysed to inform quality improvement interventions.”
What does it mean for patients? In the interest of patient safety the patients’ health records should be complete, exhaustive and include all contributions provided by all health care professionals involved in their care, including interventions made by hospital pharmacists.
What does it mean for healthcare professionals? Healthcare professionals can expect hospital pharmacists to contribute to patients ́ health records ensuring they are complete, exhaustive and accurate. This includes pharmaceutical advice, recommendations and all interventions conducted by the pharmacy team. The documentation is also necessary to support any therapeutic decision by doctors.
What does it mean for Hospital Pharmacists? Hospital pharmacists are accountable for their practice, including pharmaceutical advice, validation and any recommendation. All interventions should be documented in the patients’ health records for reasons of traceability, necessity, and patient safety. Hospital pharmacists should contribute in the definition of procedures and a classification system of such records.
The Uppsalla University Hospital is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.
The Hospital Gregorio Marañon is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.
- Clinical pharmacy›Discharge prescription Clinical pharmacy›Patient discharge Drug prescribing and dosing›Prescribing error
- COMPREHENSIVE SMOKING CESSATION PROGRAMME RUN BY CLINICAL PHARMACIST IN COLLABORATION WITH THE ADDICTOLOGY DEPARTMENT
- IMPROVING THE CONTINUITY OF CARE IN CASE OF EXTRATEMPORANEOUS MEDICINES FOR CHILDREN
- THE PHARMACIST IN THE LUNG CANCER MULTIDISCIPLINARY TEAM
- PROGRAMME OF PHARMACOTHERAPEUTIC BENEFIT TO THE SOCIO-SANITARY CENTRES OF A SPECIFIC HEALTH AREA THROUGH THE HOSPITAL PHARMACY SERVICE
- INTEGRATION OF THE CLINICAL PHARMACIST IN A MULTIDISCIPLINARY TEAM IN A BURNS UNIT
- GPI: DEFINING DOSAGE REGIMENS OF ERLOTINIB AND GEFITINIB IN NON-SMALL CELL LUNG CANCER PATIENTS USING MODELLING AND SIMULATION
- USING AN ELECTRONIC ALGORITHM TO IDENTIFY THE MOST RELEVANT PATIENTS FOR MEDICATION REVIEW
- EAHP Survey results 2016/2017 (sections 1,3 and 4)
- EAHP Survey Report 2015
- GPI: Discharge Management: Safer Discharges and Improved Information Transfer Metrics
- GPI: Development and implementation of ‘check of medication appropriateness’ in a large tertiary care centre
- GPI: Medication reviews conducted by clinical pharmacist in emergency ward
- GPI:A PHARMACIST IN THE MULTIDISCIPLINARY ONCOLOGY TEAM
- GPI: IMPLEMENTATION OF A SAFETY AND HEALTH PROGRAM FOR THE MANAGEMENT OF PATIENTS WITH HEPATITIS C IN TREATMENT WITH DIRECT-ACTING ANTIVIRAL AGENTS
- EAHP Brochure